Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Neutropenia

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on May 03, 2022 4:16pm

129 Views

Post# 34652554

RE:RE:RE:Neutropenia

Metals I agree its critical. My point was for Vertex injecting into potal vein it puts them at a higher risk needing more immonsupression. I also question why the FDA would put a stop to a dose escalation of VX-880 if they were only concerned about the immonesupressents in one patient.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec